FRED HUTCHINSON CANCER CENTER

Fred Hutch is an Equal Opportunity and VEVRAA Employer committed to a diverse and inclusive workplace. They do not discriminate based on various factors and are an Affirmative Action employer, encouraging applications from individuals with diverse backgrounds and prioritizing protected veterans. Read the EEOC Know Your Rights poster for more information.

Carl June, awarded the 2024 Breakthrough Prize in Life Sciences, developed CAR T cell immunotherapy, treating over 34,000 cancer patients. His work, recognized at the Breakthrough Prize awards, has transformed cancer treatment, with CAR T cell therapy now FDA-approved for certain cancers, marking a significant advancement in personalized medicine.

A pilot study tested a proactive financial navigation (FN) intervention for gastric/GEJ cancer patients and caregivers, showing potential to reduce financial hardship and improve quality of life. Usual care patients experienced more financial hardship (50% vs 40%) and quality of life declines (37.5% vs 0%) than intervention patients. Caregivers reported increased financial stress across both arms. Larger studies are needed to confirm these findings and explore caregiver-specific interventions.

Drew Bouton, diagnosed with metastatic prostate cancer in 2001, defied initial survival predictions through a positive attitude, innovative treatments like immunotherapy, and participation in clinical trials. His journey from fear to gratitude and family building illustrates living well with cancer, challenging the notion of a terminal diagnosis.

AI is revolutionizing healthcare by enabling personalized patient care, accelerating drug discovery, and streamlining medical research. Experts emphasize strategic, skeptical use to mitigate bias and risks, advocating for diverse datasets and rigorous clinical validation. The technology promises to transform healthcare delivery, making it more efficient and personalized, despite challenges like potential overreliance and regulatory gaps.

City of Hope and Dana-Farber Cancer Institute lead in cancer research and treatment, with national rankings and extensive clinical trials. Emory Healthcare and Northwestern Medicine offer comprehensive cancer care and research, with significant funding and patient enrollment. Fred Hutchinson Cancer Center and Kimmel Cancer Center are renowned for their innovative treatments and research in cancer and infectious diseases.

The combination of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab showed a 44% ORR in metastatic PDAC patients, with tolerable AEs and evidence of immune activation, suggesting potential for immunotherapy in pancreas cancer treatment.

2022 marked a transition in the COVID-19 pandemic, with advancements in cancer research including 40 FDA oncology drug approvals and promising immunotherapy trials. Despite progress, challenges remain in cancer prevention and treatment. The AACR emphasized the importance of e-cigarette regulation and highlighted future directions in cancer research, including immunotherapy, precision medicine, and addressing health disparities.

Dr. Bill Hutchinson founded the Fred Hutchinson Cancer Research Center in memory of his brother Fred, a baseball legend who died of lung cancer. The center, established in 1975, has become a leading institution in cancer research, pioneering treatments like bone marrow transplants and immunotherapy, and significantly impacting the life science sector in Washington State.